Novo Nordisk's market cap is currently $207.26B. The company's EPS TTM is €0.785197322; its P/E ratio is 14.11; Novo Nordisk is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is €0.70. See an overview of income statement, balance sheet, and cash flow financials.
